ClinicalTrials.gov
public full text
Public Domain
Aberrant Gene Expression Prostate Carcinoma
The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy#845609
- The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment#877104
- Table 1_The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.docx#471743
- A decision-oriented framework for genomic testing across the prostate cancer continuum.#421027
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer#916710
Record · ID 1371108
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive